Portfolio company
Biogen Idec
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops therapies for neurological, autoimmune, and hematological disorders for patients and healthcare professionals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biohaven
This biopharmaceutical company develops therapeutics for patients with debilitating neurological, neuroinflammatory, and metabolic diseases, as well as immunological and oncology disorders.
Genentech
This biotechnology company develops and manufactures medicines for patients with serious diseases including cancer, multiple sclerosis, and respiratory conditions.
Pheno Therapeutics
This biotech company develops neuroprotective and remyelinating therapies for patients with multiple sclerosis and other neurodegenerative disorders.
Clinical-stage biotech
This company develops immunomodulatory recombinant protein therapies to treat autoimmune and chronic inflammatory diseases for patients with conditions such as chronic inflammatory demyelinating polyneuropathy.
Amgen
This biotechnology company develops and manufactures biologic medicines to treat patients with serious illnesses, including cancer, kidney disease and inflammatory disorders.
Cajal Neuroscience
This biotechnology company develops drug discovery platforms and therapeutics for neurodegenerative diseases to assist healthcare providers and patients.
Micromet
This biotechnology firm develops antibody therapies for cancer and autoimmune disease treatment for patients and pharmaceutical partners.
Regeneron
This biopharmaceutical company develops medicines for serious diseases, including eye conditions, cancer and inflammatory disorders, for healthcare providers and global patients.
